Our primary scientific partner, the Brain Tumor Trials Collaborative (BTTC), through the National Institutes of Health (NIH), received $500,000 from Head for the Cure in 2017. This network of top cancer centers has received more than $4.5 million in HFTC grants since 2007 to fund investigations into new brain tumor treatments.
The BTTC has grown to more than 23 member institutions and has seen advancements in the research of alternative treatments of malignant brain tumors. Research studies, also known as clinical trials, are being conducted to learn of promising advances to cancer prevention, diagnosis and treatments that are safe and effective.
The collaborative is led by the Center for Cancer Research.
The NIH’s National Cancer Institute serves as the lead institution and provides the administrative infrastructure, clinical database and oversight for the collaborative.